Pomanda estimates the enterprise value of BIOASCENT DISCOVERY LIMITED at £20.1m based on a Turnover of £10.1m and 1.99x industry multiple (adjusted for size and gross margin).
bioascent discovery limitedEstimated Valuation
£4m
Pomanda estimates the enterprise value of BIOASCENT DISCOVERY LIMITED at £4m based on an EBITDA of £501.9k and a 7.96x industry multiple (adjusted for size and gross margin).
bioascent discovery limitedEstimated Valuation
£7.2m
Pomanda estimates the enterprise value of BIOASCENT DISCOVERY LIMITED at £7.2m based on Net Assets of £4.5m and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioascent Discovery LimitedOverview
Bioascent Discovery Limited is a live company located in edinburgh, EH1 2EN with a Companies House number of SC442915. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in February 2013, it's largest shareholder is
biocity group ltd
with a 50% stake. Bioascent Discovery Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£10.1m with
high
growth in recent years.
Pomanda's financial health check has awarded Bioascent Discovery Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
7 Strong
1 Regular
2 Weak
Size
annual sales of £10.1m, make it larger than the average company (£4.5m)
£10.1m - Bioascent Discovery Limited
£4.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 28%, show it is growing at a faster rate (13.1%)
28% - Bioascent Discovery Limited
13.1% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (53.9%)
100% - Bioascent Discovery Limited
53.9% - Industry AVG
Profitability
an operating margin of -1% make it more profitable than the average company (-4.1%)
-1% - Bioascent Discovery Limited
-4.1% - Industry AVG
Employees
with 91 employees, this is above the industry average (54)
91 - Bioascent Discovery Limited
54 - Industry AVG
Pay Structure
on an average salary of £56.7k, the company has a lower pay structure (£83k)
£56.7k - Bioascent Discovery Limited
£83k - Industry AVG
Efficiency
resulting in sales per employee of £110.7k, this is less efficient (£131.4k)
£110.7k - Bioascent Discovery Limited
£131.4k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is near the average (56 days)
50 days - Bioascent Discovery Limited
56 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Bioascent Discovery Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Bioascent Discovery Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 3 weeks, this is less cash available to meet short term requirements (30 weeks)
3 weeks - Bioascent Discovery Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.7%, this is a lower level of debt than the average (53.1%)
39.7% - Bioascent Discovery Limited
53.1% - Industry AVG
BIOASCENT DISCOVERY LIMITED financials
EXPORT
Bioascent Discovery Limited's latest turnover from December 2023 is £10.1 million and the company has net assets of £4.5 million. According to their latest financial statements, Bioascent Discovery Limited has 91 employees and maintains cash reserves of £171.4 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Turnover
10,072,328
9,733,106
6,860,996
4,748,985
4,036,652
1,796,229
575,068
243,650
254,034
449,422
Other Income Or Grants
Cost Of Sales
3,373,830
2,274,274
2,040,616
884,554
294,794
128,997
136,285
235,175
Gross Profit
10,072,328
9,733,106
3,487,166
2,474,711
1,996,036
911,674
280,274
114,654
117,749
214,246
Admin Expenses
10,168,728
8,884,303
3,176,086
3,292,792
2,230,308
-3,462,064
877,370
1,033,194
906,819
1,162,492
92,524
Operating Profit
-96,400
848,803
311,080
-818,081
-234,272
4,373,738
-597,096
-918,540
-789,070
-948,246
-92,524
Interest Payable
131,340
117,330
143,616
33,199
137,896
259,247
237,406
290,615
170,170
Interest Receivable
2,079
1,200
946
2,685
1,940
Pre-Tax Profit
-227,740
731,473
167,464
-851,280
-234,272
4,237,921
-855,143
-1,155,000
-1,077,000
-1,116,476
-92,524
Tax
85,689
57,858
293,527
93,123
229,149
-805,205
Profit After Tax
-142,051
789,331
460,991
-758,157
-5,123
3,432,716
-855,143
-1,155,000
-1,077,000
-1,116,476
-92,524
Dividends Paid
Retained Profit
-142,051
789,331
460,991
-758,157
-5,123
3,432,716
-855,143
-1,155,000
-1,077,000
-1,116,476
-92,524
Employee Costs
5,162,349
3,992,982
3,006,959
2,888,404
2,120,682
1,015,490
485,626
173,090
164,325
281,584
53,258
Number Of Employees
91
80
57
41
31
15
8
3
3
5
1
EBITDA*
501,879
1,388,105
695,131
215,987
333,832
4,936,880
-597,096
-28,540
98,930
-948,246
-92,524
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Tangible Assets
3,641,307
3,799,089
3,868,984
2,668,800
2,805,672
1,126,612
1,686,656
2,574,000
3,463,000
4,348,000
Intangible Assets
35,739
71,479
107,218
68,533
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
3,641,307
3,834,828
3,940,463
2,776,018
2,874,205
1,126,612
1,686,656
2,574,000
3,463,000
4,348,000
Stock & work in progress
403,472
383,365
406,576
381,050
383,655
352,940
310,940
316,000
318,000
348,000
Trade Debtors
1,389,549
1,445,373
965,116
453,980
367,278
374,021
51,324
17,000
11,000
28,000
Group Debtors
Misc Debtors
1,925,912
1,248,112
806,225
410,272
585,887
1,200,014
562,669
21,000
43,000
8,687
Cash
171,449
294,201
1,202,961
965,063
1,030,945
533,510
20,869
459,000
298,000
776,000
misc current assets
total current assets
3,890,382
3,371,051
3,380,878
2,210,365
2,367,765
2,460,485
945,802
813,000
670,000
1,152,000
8,687
total assets
7,531,689
7,205,879
7,321,341
4,986,383
5,241,970
3,587,097
2,632,458
3,387,000
4,133,000
5,500,000
8,687
Bank overdraft
Bank loan
Trade Creditors
879,706
300,232
642,077
338,169
192,609
173,494
27,647
64,000
113,000
142,000
Group/Directors Accounts
843,413
670,992
65,000
96,457
other short term finances
250,000
hp & lease commitments
587,037
584,918
524,965
124,109
127,906
other current liabilities
556,999
630,887
854,513
448,119
584,429
330,373
63,100
793,000
455,000
980,000
3,000
total current liabilities
2,273,742
1,516,037
2,021,555
910,397
904,944
1,347,280
761,739
857,000
633,000
1,122,000
99,457
loans
4,085,819
3,891,000
3,706,000
5,236,000
hp & lease commitments
713,430
1,003,274
1,402,549
639,740
142,623
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
713,430
1,003,274
1,402,549
639,740
142,623
4,085,819
3,891,000
3,706,000
5,236,000
total liabilities
2,987,172
2,519,311
3,424,104
1,550,137
1,047,567
1,347,280
4,847,558
4,748,000
4,339,000
6,358,000
99,457
net assets
4,544,517
4,686,568
3,897,237
3,436,246
4,194,403
2,239,817
-2,215,100
-1,361,000
-206,000
-858,000
-90,770
total shareholders funds
4,544,517
4,686,568
3,897,237
3,436,246
4,194,403
2,239,817
-2,215,100
-1,361,000
-206,000
-858,000
-90,770
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Operating Activities
Operating Profit
-96,400
848,803
311,080
-818,081
-234,272
4,373,738
-597,096
-918,540
-789,070
-948,246
-92,524
Depreciation
562,540
503,562
348,312
1,034,068
568,104
563,142
890,000
888,000
Amortisation
35,739
35,740
35,739
Tax
85,689
57,858
293,527
93,123
229,149
-805,205
Stock
20,107
-23,211
25,526
-2,605
30,715
42,000
-5,060
-2,000
-30,000
348,000
Debtors
621,976
922,144
907,089
-88,913
-620,870
960,042
575,993
-16,000
26,000
19,313
8,687
Creditors
579,474
-341,845
303,908
145,560
19,115
145,847
-36,353
-49,000
-29,000
142,000
Accruals and Deferred Income
-73,888
-223,626
406,394
-136,310
254,056
267,273
-729,900
338,000
-525,000
977,000
3,000
Deferred Taxes & Provisions
Cash flow from operations
451,071
-18,441
766,345
409,878
1,426,307
3,542,753
-1,934,282
278,460
-451,070
-196,559
-98,211
Investing Activities
capital expenditure
-935,881
-2,315,697
-3,098
887,344
-1,000
-3,000
-4,348,000
Change in Investments
cash flow from investments
-935,881
-2,315,697
-3,098
887,344
-1,000
-3,000
-4,348,000
Financing Activities
Bank loans
Group/Directors Accounts
-843,413
172,421
670,992
-65,000
65,000
-96,457
96,457
Other Short Term Loans
250,000
Long term loans
-4,085,819
194,819
185,000
-1,530,000
5,236,000
Hire Purchase and Lease Commitments
-287,725
-339,322
1,163,665
493,320
270,529
other long term liabilities
share issue
1,959,709
1,022,201
1,043
1,729,000
349,246
1,754
interest
-131,340
-117,330
-143,616
-33,199
-135,817
-258,047
-236,460
-287,930
-168,230
cash flow from financing
-169,065
-456,652
1,020,049
460,121
1,386,825
-3,027,014
608,807
-116,460
-23,930
5,320,559
98,211
cash and cash equivalents
cash
-122,752
-908,760
237,898
-65,882
497,435
512,641
-438,131
161,000
-478,000
776,000
overdraft
change in cash
-122,752
-908,760
237,898
-65,882
497,435
512,641
-438,131
161,000
-478,000
776,000
bioascent discovery limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for bioascent discovery limited. Get real-time insights into bioascent discovery limited's credit score, group structure and payment trends.
Perform a competitor analysis for bioascent discovery limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in EH1 area or any other competitors across 12 key performance metrics.
bioascent discovery limited Ownership
BIOASCENT DISCOVERY LIMITED group structure
Bioascent Discovery Limited has no subsidiary companies.
Ultimate parent company
BIOASCENT DISCOVERY LIMITED
SC442915
BIOASCENT DISCOVERY LIMITED Shareholders
The largest shareholders in Bioascent Discovery Limited include Biocity Group Ltd and Maven Income & Growth Vct 6 Plc.
biocity group ltd
50%
maven income & growth vct 6 plc
21.76%
maven income & growth vct 3 plc
6.22%
maven income & growth vct 4 plc
6.22%
maven income & growth vct plc
5.44%
maven income & growth vct 5 plc
5.44%
maven income & growth vct 2 plc
4.66%
maven capital partners uk llp
0.25%
sylviane jeanine boucharens
0.01%
bioascent discovery limited directors
Bioascent Discovery Limited currently has 6 directors.
The longest serving directors include
Dr Glenn Crocker (Feb 2013) and
Dr Sylviane Boucharens (Oct 2013).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to bioascent discovery limited. Currently there are 1 open charges and 1 have been satisfied in the past.
bioascent discovery limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOASCENT DISCOVERY LIMITED. This can take several minutes, an email will notify you when this has completed.
bioascent discovery limitedCompanies House Filings - See Documents
